FAILURE TO DECREASE ANTIBODY LEVELS IN SENSITIZED PATIENTS BY REPEATED TRANSFUSIONS FROM ONE DONOR AND CYCLOSPORINE

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Transplantation

• Publication date

  1988-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00007890-198801000-00056PMID 3276056
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• SUPPRESSION OF ANTIBODY RESPONSE AND PROLONGATION OF SKIN GRAFT SURVIVAL BY MULTIPLE BLOOD TRANSFUSIONS IN THE RAT

  1985cited by this paper
• Successful renal transplantation in patients with T-cell reactivity to donor.

  1982cited by this paper
• Lymphocytotoxic antibody responses to transfusions in potential kidney transplant recipients.

  1981cited by this paper
• EFFECT OF CYCLOSPORIN A UPON SECOND‐SET REJECTION OF RAT RENAL ALLOGRAFTS

  1980cited by this paper

• The Programmed Death (PD)‐1/PD‐Ligand 1 Pathway Regulates Graft‐Versus‐Host‐Reactive CD8 T Cells After Liver Transplantation

  2008cites this paper
• The immunologically sensitised renal transplant recipient: the impact of advances in technology on organ allocation and transplant outcome

  1999cites this paper
• Transfusion Support in Solid-Organ Transplantation

  1998cites this paper
• Graft Versus Host Response: Clinical and Biological Relevance After Transplantation of Solid Organs

  1996cites this paper
• IgM AND IgG ALLOANTIBODY RESPONSES TO MHC CLASS I AND II FOLLOWING RAT RENAL ALLOGRAFT REJECTION: EFFECTS OF TRANSPLANTECTOMY AND POSTTRANSPLANTATION BLOOD TRANSFUSION1,2

  1992cites this paper
• An anatomy of rejection

  1991cites this paper
• Cyclosporine-induced autoimmunity and immune hyperreactivity.

  1991cites this paper
• Alloantibodies: Basic and clinical concepts

  1991cites this paper
• Blood and blood products

  1989cites this paper
• Anti-idiotypic activity in cytotoxic sera from highly sensitised patients (HSP) given cyclosporin A and blood transfusion from a specific donor (ST).

  1989cites this paper
• Antibodies and graft rejection.

  1989cites this paper